452653
2,3-二氢-9,10-二羟基-1,4-蒽二酮
90%
别名:
醌茜隐色体
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C14H10O4
化学文摘社编号:
分子量:
242.23
UNSPSC Code:
12352100
PubChem Substance ID:
EC Number:
241-631-3
MDL number:
assay
90%
form
solid
mp
154-157 °C (lit.)
SMILES string
Oc1c2C(=O)CCC(=O)c2c(O)c3ccccc13
InChI
1S/C14H10O4/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-4,17-18H,5-6H2
InChI key
FVXPBEUYCCZFJT-UHFFFAOYSA-N
Other Notes
残留物为醌茜
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
法规信息
新产品
此项目有
A comparison of vapour pressure measurements of quinizarin and leuco-quinizarin via transpiration and thermogravimetry
Hinks D, et al.
Coloration Technology, 119(2), 84-90 (2003)
Reactions of 2, 3-dihydro-9, 10-dihydroxy-1, 4-anthracenedione (leucoquinizarin) with hydrazine and substituted hydrazines.
Krapcho AP, et al.
The Journal of Organic Chemistry, 55(16), 4960-4961 (1990)
Gregory I Giles et al.
Journal of peptide science : an official publication of the European Peptide Society, 11(7), 417-423 (2005-01-11)
Anthraquinone peptide derivatives have previously been shown to inhibit the enzyme topoisomerase I (topo I), a pharmaceutical target for the prevention of malignant carcinomas. A highly efficient procedure for the attachment of the anthraquinone moiety to the N-terminus of a